img28


Cosmetic genital surgery - labiaplasty and
phalloplasty:
http://www.betterhealth.vic.gov.au/bhcv2/bhcarticles.nsf/pages/Cosmetic_genital_surgery_labiaplasty_and_phalloplasty?open

Cosmetic genital surgery involves reshaping the labia, vulva or penis. Some people opt for this surgery because they
feel unhappy about the look of their genitals. An operation to change the look of the genitals is sometimes referred to
as ‘aesthetic genital surgery’.
Female genital reshaping or labiaplasty aims to change the size and shape of the inner labia or the inner lips of the
vulva. Penis enlargement or augmentation surgery (phalloplasty) is used to increase length, width or both of the penis.
Labiaplasty and phalloplasty are not the same as gender reassignment surgeries.
If you are concerned about the way you look or are thinking about cosmetic treatments to boost your confidence,
there are alternatives. Another option is to accept yourself the way you are and realise that normal, healthy genitals
come in a wide range of shapes and sizes.

Things to consider:

Before you opt for cometic genital surgery, there are some important issues to keep in mind:
Be aware that you will have scars. Although the scars may fade significantly with time, they will always be
visible.
Labiaplasty will not make the vagina smaller or tighter. This requires a different operation called a vaginoplasty.
Phalloplasty can only increase the length or width of the penis shaft, not the head.
Phalloplasty to lengthen the penis will only make the penis appear longer when flaccid – it will not be longer
when erect.

Think about the financial burden. Cosmetic surgery does not usually qualify for rebates from Medicare or private
health insurance companies.
Smokers are at increased risk of complications. If you are serious about undergoing cosmetic surgery, you
should quit try to smoking.

Finding a surgeon

You may want to ask your doctor (GP) for advice on a suitable and reputable doctor or hospital where cosmetic
genital surgery is performed. At your first consultation, you should ask the surgeon about their training and
experience. It is preferable to have this procedure done by a reputable professional who is specially trained to perform
cosmetic genital surgery and has a lot of experience in carrying out this type of surgery.

Medical issues

Before surgery, you need to discuss a range of medical issues with your doctor or surgeon including:
Physical health – an examination will help your doctor or surgeon to decide if the treatment is appropriate.
Medical history – some pre-existing conditions and surgeries you have had in the past may influence
decisions about this operation, including the type of anaesthetic that is used.
Psychiatric history – some surgeons may suggest or insist that you receive counselling before you consider
cosmetic genital surgery.
Risks and possible complications – it is important that you understand the risks and complications so that
you can weigh up whether cosmetic genital surgery is right for you.
Medications – tell the surgeon about any that you take on a regular basis or have recently taken, including
over-the-counter preparations like fish oils and vitamin supplements.
Past reactions to drugs – tell the surgeon if you have ever had a bad reaction or a side effect from any drugs
including anaesthesia.

Preparation for surgery – your surgeon will give you detailed instructions on what you should do at home to
prepare for surgery. For example, you may be advised to take a particular drug or alter the dose of an existing
medication. Follow all instructions carefully.

The operation

The details of the surgery will depend on individual factors, but generally include:
Labiaplasty – the operation is usually performed to reduce the size of the labia minora (inner lips). General or
local anaesthesia may be used. The surgeon removes the unwanted tissue and remodels the labia into the
desired size and shape. Alternatively, a wedge-shaped section of the labia is removed. Some surgeons use a
laser instead of a scalpel to reduce bleeding. Occasionally, a labiaplasty is performed to reduce the size of the
labia majora (outer lips). Some women choose to have surgery to tighten the vagina (vaginoplasty) during the
same operation.

Enlargement phalloplasty
– this operation increases penis length. General or local anaesthesia may be used.
The surgeon makes an incision (cut) at the base of the penis and cuts the ligament that attaches the penis to
the body. This will cause the penis to extend out further from the body. The penis is not actually longer but
more of it is visible.
Girth enlargement phalloplasty – this operation increases the width of the penis. General or local anaesthesia
may be used. Using fatty tissue harvested (removed) from another part of your body, the surgeon may sew
strips of fat underneath the skin of the penis (dermal fat grafting) or inject fat into the penis (fat transfer or fat
transplant).
Full phalloplasty – some men choose to have the penis increased in both length and girth during the same
operation.

After the operation, you may expect:
Bruising and swelling
Possible numbness
Pain and discomfort
To wear dressings or bandages.
Possible complications

All surgery carries some degree of risk. Some of the possible complications of cosmetic genital surgery include:

Risks of general anaesthesia including allergic reaction, which may (rarely) be fatal
Surgical risks such as bleeding or infection
Scars that may be severe, raised, reddened and itchy
Unevenness – the labia may not be symmetrical
Permanent colour change to the labia
Nerve damage to the labia or penis including permanent loss of sensation
Irregular shape to the penis following fat transfer
Impotence (inability to get or maintain a erection)
Tissue death along the wound or skin loss
Further surgery to treat complications.

This is not a complete list. For example, your medical history or lifestyle may put you at increased risk of certain
complications. You need to speak to your surgeon for more information.

Taking care of yourself at home
Recovery may take at least six weeks. Be guided by your surgeon, but general self-care suggestions include:
Follow all instructions on looking after your wounds.
Wear penile weights as directed for a few weeks after you have phalloplasty.
Avoid sex for at least six weeks.
Report any bleeding, severe pain or unusual symptoms to your surgeon.

Long-term outlook
Scarring will be permanent but should fade in time. Be patient – improvements to scars may take around a year or so.
The results of labiaplasty are permanent. If fat transfer has been used to widen the penis, this is not permanent and it
will disappear over time because the body tends to reabsorb about 50 per cent of the injected fat. Top-up injections
may be required. Following phalloplasty to lengthen the penis, the angle of the erection may be lower but this should
not affect sexual intercourse.

Other options
Most people choose to have cosmetic genital surgery because they are unhappy with their appearance. However,
some people may not realise that normal, healthy genitals come in a wide range of shapes and sizes. If you are
concerned about your appearance, talking to a counsellor or psychologist may help you overcome your concerns and
you may decide that you like yourself the way you are.

The Australian Society of Plastic Surgeons Information Hotline Tel. 1300 367 446
Royal Australasian College of Surgeons Tel. (03) 9249 1200
Australian Health Practitioner Regulation Agency Tel. 1300 419 495
Things to remember
Female genital re-shaping or labiaplasty is performed to change the size and shape of the inner labia, the inner
lips of the vulva.

Penis enlargement or augmentation surgery (phalloplasty) is performed to increase penis length, girth or both.
Labiaplasty and phalloplasty are not gender reassignment surgeries.
Talk with your surgeon about the risks and benefits of aesthetic genital surgery and what results you can
expect.
This page has been produced in consultation with and approved by:
The Australian Society of Plastic Surgeons

Content on this website is provided for education and information purposes only. Information about a therapy, service, product or treatment
does not imply endorsement and is not intended to replace advice from your qualified health professional.
For the latest updates and more information, visit www.betterhealth.vic.gov.au
Copyight © 1999/2011 State of Victoria. Reproduced from the Better Health Channel (www.betterhealth.vic.gov.au) at no cost with
permission of the Victorian Minister for Health.

History of the Vibrator...
In the late part of the 19th Century,women were reporting to their doctors feelings of heaviness in their lower parts, being moody , experiencing headaches, being anxious, symptoms that were often diagnosed as "hysteria"hysteria. After awhile these symptoms were coined “hysteria pandemic”!.
posters
And so, women started visiting their doctors to ‘relieve’ the symptoms of hysteria by massaging the vulva. This would induce “hysterical paroxysm” otherwise known as an orgasm!!
As it was such a ‘hands on’ job an entrepreneurial Doctor invented the first vibrator. The first vibrator consisted with a contraption the used jets of water to the common handheld, electric power devices the size of a large hairdryer.  These electric vibrators were not small enough or cheap enough to be sold for home use and thus were marketed for the health and wellbeing of women (Sears Reebok carried them in their catalogues). By 1917 there were more vibrators in American homes than toasters!!!
By the late1920's vibrators began appearing in so called ‘stag’ films and the vibrator slipped out of the mainstream as perceptions of the vibrator shifted from the health and wellbeing benefits to a more sexualized image. From the 1950's to 1970's mail-order catalogues were full of ‘camouflaged vibrators’, ranging from nail buffer kits through to attachments for vacuum cleaners!  Thankfully, not only have times changed for women, the designs have too with the creation of the Be Be!
To learn more about this fascinating piece of history, click on the link
www.technologyoforgasm.com
vibrators
For more information visit: http://www.facebook.com/l/4e5699LK95NwqsSdAHJd8-PETJw/www.lovebeingwoman.com/

Semen as an Antidepressant
A recent study has suggested that semen acts as an antidepressant in women, so that women physically exposed to semen are less likely to suffer from depression.
It is thought that the psychological effects of
semen are a result of its complex chemical make-up including several mood-altering hormones (testosterone, oestrogen, follicle-stimulating hormone, luteinizing hormone, prolactin and several different prostaglandins).
In a scientific survey of 293 college women it was also found that those who did not use condoms were most likely to initiate sex and to seek out new partners as soon as a relationship ended, suggesting that the chemical dependency to
semen creates a "rebound effect".
The effect of
semen on a male sexual partner (a receiver of semen) is not known.
Further Reading


This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Semen" All material adapted used from Wikipedia is available under the terms of the GNU Free Documentation License. Wikipedia® itself is a registered trademark of the Wikimedia Foundation, Inc.


South Africa: "Corrective Rape"

QVjaxeggZJNvQWY-250
"Corrective Rape" is a term used to describe when a male rapes a lesbian with the aim of 'turning' her heterosexual!
This heinous crime is prolific in South Africa, especially in the "townships". 
Most of the victims are tortured, grievously assaulted and sometimes murdered! They are also prone to getting HIV/AIDS from the assault, and many of them commit suicide as a result of the "corrective rape"!
The South African government and justice system are failing the victims of Corrective Rape by letting the perpetrators out on
ridiculously low bail, and taking literally years to bring the court-cases to a conclusion. In the meantime the victims have to live with seeing and being taunted and threatened by their rapists every day, as do those who help the victims!
In the last 10 years:
 *31 lesbian women have been murdered because of their sexuality  *More than 10 lesbians a week are raped or gang raped in Cape Town alone  *150 women are raped every day in South Africa  *For every 25 men accused of rape in South Africa, 24 walk free
Despite all this, hate crimes on the basis of sexual orientation are not recognised by South African law!


VAGINISMUS AND BOTOX

Vaginismus is spasm of the vaginal muscles that results in response to the fear of vaginal penetration. It can be thought of as a phobia and like any phobia the fear is exaggerated and often the patient is compromised because of the phobia. As with a phobia there are varying degrees of severity. The causes of vaginismus are generally thought to be unknown though in our own group of patients there is a high percentage of some type of psychosexual trauma such as hearing about bleeding and tearing with the first intercourse, strict sexual upbringing sometimes with religious overtones (going to “hell” if you have intercourse before marriage), fear of childbirth, rough GYN exams, and sexual molestation at a young age. It is the leading cause of unconsummated marriages and afflicts women worldwide.
One-to-Six Percent of Women have Vaginismus
Women who suffer from vaginismus usually cannot tolerate any form of penetration including tampon, speculum, finger or penis. The exact incidence of vaginismus is not clear because many women and doctors are not aware of this disorder, and therefore this condition is underreported. Further, women tend to maintain a wall of silence regarding this. Studies quote an incidence of 1-6% which represents an enormous number of women worldwide.
Conservative measures to treat vaginismus
Numerous conservative measures are used to treat vaginismus, but none of the treatments are scientifically evidence based. Further, the more severe forms of vaginismus do not respond to any of these treatments. Often over a course of years women will spend time, effort and money on treatments such as: Psychotherapy, hypnotherapy, physical therapy, sex counseling, lubricants, topical anesthetics, muscle relaxants, anti-anxiety medications, anti-depressants, and therapy with dilators.  As they move from treatment to treatment they become more frustrated with themselves and see their relationships falling apart.
Our program of Botox and Dilators under Anesthesia and Post Procedure Care for Vaginismus
Botox has been used worldwide to treat vaginismus and appears to be highly effective. We continue to have a success rate of over 90 percent allowing women to progress to painless intercourse. Our program includes the injection of Botox into the spastic vaginal muscles and progressive dilation of the vagina all done under anesthesia. The patient and her partner are then counseled for about 3 days working with progressive dilation as well as educational sessions for post procedure care. This allows them to advance to intercourse in their own home environment. Once treated, most women are able to achieve painless intercourse within 2 weeks to 3 months. In most cases one treatment is all that is needed and the recurrence rate is extremely low.
Contact Us for More Information
For confidential personalized information and advice, please complete our information request form or call us at 1-800-640-0290 during business hours: Monday through Thursday 8:30 a.m. - 4:30 p.m. and Friday 8:30 a.m. - 4 p.m. EST. LATE AFTERNOON & EVENING HOURS NOW AVAILABLE .
The Plastic Surgery Center of Manchester, New Hampshire specializes in cosmetic plastic surgery, including body lifts, breast enlargements, breast lifts, breast reductions, eyelid surgery, ear surgery, facelifts, fat grafting, liposuction, male breast reductions (gynecomastia), neck and chin surgery, nose surgery (rhinoplasty), surgery after massive weight loss, tummy tucks and BOTOX® Cosmetic for vaginismus. We also offer facial rejuvenation (chemical peels, dermabrasion, Obagi Blue Peels, Glycolic Peels, Microdermabrasion), injectables and facial fillers (BOTOX® Cosmetic, Radiesse®, Juvederm®, Perlane® and Restylane®) and advanced skin care to patients from all over New England (Maine, Vermont, New Hampshire, Massachusetts). While no responsible practitioner gives guarantees for the work they do on the human body, we can at least reassure you that you will receive the expertise and dedication of over 30 years in practice. Our patients become an important part of our family and we try to get to know each patient individually and customize their treatment to meet their desires. Visit our skincare website to purchase MD Forte, Obagi-C Rx, Obagi NuDerm, Prevage and Vivite advanced skincare products.

Genital Herpes Vaccine Ineffective in Women, Study Suggests.
Summary of current program using Botox for Vaginismus as of January 2010
What is Vaginismus?
ScienceDaily (Sep. 30, 2010) — An experimental vaccine intended to prevent genital herpes disease in women, although generally safe and well-tolerated, proved ineffective when tested in the recently concluded clinical study known as the Herpevac Trial for Women.
The Phase 3 trial, sponsored by GlaxoSmithKline (GSK) Biologicals, based in Belgium, with support from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, began in 2002. A total of 8,323 women aged 18-30 years participated in the trial at 50 sites in the United States and Canada. At the time of their enrollment, the study participants were free of the two types of herpes simplex viruses (HSV), HSV-1 and HSV-2.
Participants in the Herpevac trial were randomly divided into two groups. One group received the candidate vaccine, containing HSV protein along with an adjuvant intended to boost immune responses. The second, control group received a version of Havrix, a licensed vaccine against hepatitis A. This study design gave all participants the potential opportunity to be protected against either genital herpes or hepatitis A. GSK developed the candidate vaccine and also manufactures Havrix.
Each volunteer was vaccinated at the beginning of the study and again one and six months later. The participants were followed for 20 months after the initial injection and evaluated at each visit for HSV infection and genital herpes disease.
In two earlier studies involving men and women who did not have genital herpes but whose sexual partners were known to be infected, the candidate vaccine prevented genital herpes disease in more than 70 percent of the female volunteers who were free of HSV-1 and HSV-2 but had no clear effect in men. These studies formed the basis to conduct the larger Herpevac study in women only.
In the Herpevac study, however, the investigational vaccine was ineffective in protecting against genital herpes disease. The estimate of vaccine effectiveness was 20 percent, but all estimates have statistical uncertainty, and this effect was not substantially different from zero.
It is not known at this time why the vaccine proved ineffective, but the study collaborators continue to evaluate the trial data and intend to provide a more detailed analysis at a later date.
All the study investigators have been informed of the results. Study participants are being notified as to which vaccine they received, and those volunteers who received the candidate herpes vaccine are being offered Havrix.
HSV-1 and HSV-2, which cause cold sores and genital herpes disease, may be transmitted through sexual or other skin-to-skin contact, and can be spread even when the infected individual shows no symptoms. HSV can cause severe illness in infants born to HSV-infected women, and the virus has been identified as a risk factor for HIV transmission in adults. An estimated 1 in 4 women in the United States has genital herpes.
Story Source:
The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by NIH/National Institute of Allergy and Infectious Diseases.
Need to cite this story in your essay, paper, or report? Use one of the following formats:
APA

MLA
NIH/National Institute of Allergy and Infectious Diseases (2010, September 30). Genital herpes vaccine ineffective in women, study suggests.
ScienceDaily. Retrieved October 1, 2010, from http://www.sciencedaily.com­ /releases/2010/09/100930101549.htm

Knowing cultural view of virginity, Chinese women try surgical restoration
By Keith B. Richburg in beijing Tuesday, August 17, 2010; A06
China has long been known as the land of fakes -- Rolexes, DVDs, handbags and designer clothes.
Add a new one to the list: fake virgins.
A growing number of Chinese women -- mostly in their 20s and about to get married -- are opting for a surgical procedure called "hymen restoration," which returns the hymen to its condition before it was ruptured, which typically occurs during first sexual contact but can also happen while playing sports or doing other strenuous activities.
Even as China has flung open its doors to the West and modernized, a deeply conservative and chauvinistic attitude persists. Many men, including white-collar professionals, say they want to marry a virgin. And increasingly liberated Chinese women have found a way to oblige them.
"We can fix it so everything is perfect, so the men can believe they are marrying virgins," said Zhou Hong, a physician and director of gynecology at the Beijing Wuzhou Women's Hospital. "We don't advertise it; we don't publicize it."
Zhou, 44, said most of her patients are sexually active young women who are about to marry and have told their future husbands they are virgins. She said a smaller number want to forget a bad relationship and "start over," and a few have been victims of rape.
Zhou is one of many Chinese doctors performing the procedure, which is also done in other countries. She said she restores as many as 20 hymens a month, and the number is increasing. For as little as 5,000 renminbi, or about $737, for a 20-to-30-minute procedure, Zhou is giving women a second chance at having a first time.
Does she worry that she is encouraging people to start their marriages with a lie? "It's just a white lie," Zhou said. And she blames men for having unrealistic expectations.
"I don't agree with this value" placed on virginity, Zhou said. "It's unfair to the women. The men are not virgins. But we can't change this male-privileged society."
The surgery, known as hymenoplasty, has been around for years, although it is considered rare and is illegal in some countries. It is performed primarily in Muslim countries, where the traditionalists place a high value on a woman's virginity. It also has become common in
France among French Muslims, usually for young women about to enter a traditional marriage. There are no statistics available in China on how often the surgery is performed. But sociologists and other experts, as well as anecdotal evidence, suggest it has gained in popularity.
For women who do not want to have surgery, a cheaper, faster path to "revirgination" is available in most sex novelty shops: a Chinese-made artificial hymen that purports to create a physical sensation for the man and emit fake blood when ruptured.
A 25-year-old woman from Guiyang recently bought several online, intending to resell them to young women in her circle. Some of her friends, she said, were worried that their boyfriends might leave if the truth about their virginity was known.
"It's really worthless for couples to break up over this small issue," said the woman, who asked not to be quoted by name.
Some sociologists and others have criticized the virginity obsession as emblematic of a male-dominated society in which women are viewed as sex objects. And they are equally critical of women undergoing potentially dangerous or painful medical procedures to conform.
"I think it is really stupid for women to do this kind of surgery and buying fake hymens," said Li Yinhe, a sociologist at the Chinese Academy of Social Sciences and the country's preeminent sexologist. "It's self-deception."
The virginity topic has surfaced in recent newspaper columns and Internet debates. Several men posting comments on a popular Web site blamed women for what they called modern women's materialism when seeking a mate.
"Women demand men have houses and cars, why can't men demand women be virgins?" asked one man on the Tianya site. "So, greedy women, remember, you have to protect your hymens, because those are big dowries for you to exchange for money."
Some men who were interviewed agreed about the importance of finding a virgin. "I really care about virginity," said Xia Yang, product manager for a technology company. "If you go to buy a cellphone, of course you'd want to buy a new cellphone. Who would spend the same amount of money to buy an old cellphone that's been used for two years?"
The virginity debate also underscores a contradiction in modern China: As the nation becomes more freewheeling, there remains a deeply conservative core.
"Since the reforms began 30 years ago, sexual relations in China are actually quite chaotic," said Chen Lan, a novelist and social commentator. "One-night stands, extramarital affairs, prostitution. . . . All this means Chinese women have more frequent sexual activity, and at a younger and younger age. And this makes men feel women's bodies are not as clean as before. In these circumstances, men care even more about a woman's virginity."
Zhou, the gynecologist, is unruffled by the controversy.
She said that she hears from satisfied clients after they are married, women who text-message her to say that the wedding night was a success.
"That's the happiest thing for us," she said.
Researcher Liu Liu in Beijing contributed to this report.


Pasted Graphic
Gilead AIDS drug safe for HIV prevention in study
By Kate Kelland
VIENNA (Reuters) - Gilead's HIV drug tenofovir is safe to be given to men at high risk of contracting the virus as a preventative measure, scientists said on Friday, but further trials are needed to test its efficacy.
Researchers from the Centers for Disease Control and Prevention (CDC) in the United States studied the safety of the drug in gay and bisexual men who did not have the human immunodeficiency virus (HIV) that causes AIDS and said their results showed there were no concerns.
"We didn't find any increased risk of harm in medical terms, and on the behavioral side the preliminary work we've done also suggests there is no increased risk," said Lisa Grohskopf, who led the study and presented the findings at the International AIDS Conference in Vienna.
The approach of taking a daily antiretroviral drug to try to prevent HIV infection is known as pre-exposure prophylaxis, or PrEP. Scientists around the world are currently conducting studies to see if it may be an effective way to reduce HIV infection in high-risk groups, including gay men.
A previous study in Ghana, Nigeria and Cameroon found that the Gilead drug was also safe when given to heterosexual women at high risk of contracting HIV.
South African researchers presented research at the Vienna conference on Monday which showed that a microbicide gel also containing Gilead's tenofovir can sharply reduce HIV infections in women.
More than 2.7 million people around the world become newly infected with HIV each year and 33.4 million people are currently living with the virus.
Although prevention methods such as using male or female condoms can be very effective, many people don't use them and scientists are constantly searching for other ways of trying the prevent the incurable virus from spreading.
This trial looked at whether a 300 milligram tablet of tenofovir taken daily was safe among 400 HIV-negative gay men in San Francisco, Atlanta, and Boston.
The men were divided into four groups. Two groups were started immediately on either tenofovir or a placebo, or dummy pill, while the other two received either tenofovir or a placebo nine months after the start of the study. This design allowed researchers to compare risk behaviors among those taking a daily pill and those not taking pills.
"It is conceivable that if someone was taking a pill and thought that it was effective (in preventing HIV infection) that it might lead to a greater likelihood of risky behavior," Grohskopf explained.
The researchers said they were "encouraged" that no serious safety concerns emerged in the trial. There were also no serious side effects and no significant differences in effect on kidney function between those taking tenofovir and those on a placebo.
"If PrEP proves effective it could provide an additional safety net for men who have sex with men and other individuals at high risk, when used in combination with other proven prevention strategies," they said.
(Editing by
Ben Hirschler, Greg Mahlich)
 Elderly Staying Sexually Active
Rob Stein, Washington Post Staff Writer Thursday, August 23, 2007; A01
Many people maintain rich, active sex lives well into their 80s, according to the first detailed examination of sexuality among older Americans.
The nationally representative survey of more than 3,000 U.S. adults ages 57 to 85 found that more than half to three-quarters of those questioned remain sexually active, with a significant proportion engaging in frequent and varied sexual behavior.
Sexual problems do increase with age, and the rate of sexual activity fades somewhat, the survey found. But interest in sex remains high and the frequency remains surprisingly stable among the physically able who are lucky enough to still have partners.
"There's a popular perception that older people aren't as interested in sex as younger people," said Stacy Tessler Lindau of the University of Chicago, who led the study, being published today in the New England Journal of Medicine. "Our study shows that's simply not true. Older people value sexuality as an important part of life."
"This study paints a portrait of this aspect of older Americans' lives that suggests a previously uncharacterized vitality and interest in sexuality," agreed Georgeanne E. Patmios of the National Institute on Aging, the primary funder of the study. "This has not perhaps been fully appreciated."
The survey found a close link between sex and health, with healthier people reporting the highest rates of sexual activity. In addition to supporting the well-known idea that illness can interfere with sex, that finding suggests that a healthy sex life may itself help keep people vibrant, the researchers said.
"Individuals who remain sexually active gain the benefit of the physical exercise that comes with sex," Lindau said. "It's also possible the hormones -- the endorphins released by orgasms -- give a general sense of well-being that could be beneficial. The psychological benefits of being loved and cared for may also trickle over to physical health."
Despite the intense focus on sex in popular culture, political sensitivities have severely limited funding for reliable, detailed studies of sexual activity among Americans of any age. Smaller, more limited studies have provided glimpses into the sex lives of the elderly, but no one had previously attempted an in-depth, nationally representative survey among this rapidly growing segment of the population.
"We just don't know very much about sexuality in the later years," said Robert N. Butler, president of the International Longevity Center in New York, a nonprofit think tank. "There's been a tremendous amount of resistance to such studies. That's what makes this so terrific."
For the study, researchers conducted face-to-face interviews with a randomly selected sample of 3,005 Americans from July 2005 to March 2006.
"We found people to be grateful to have an opportunity to discuss these issues," said Lindau, noting that researchers achieved an unusually high 75 percent response rate from those they approached. "The topics we were asking about resonated with people. Many said they had never had a chance to talk to anyone about these issues, not even a spouse or their physicians."
About 28 percent of men and about 14 percent of women said sex was very important, and about three-quarters of those with partners reported being sexually active, which is about equivalent to what previous research had found for people in their 40s and 50s. Being sexually active was defined as having had mutually voluntary sexual contact with another person within the past 12 months.
"Our findings indicate that when it comes to sexual activity, older people are really just younger people later in life," Lindau said "There's no reason to believe they give up the basic human desire for love and intimacy and the kind of pleasure that comes from intimate relationships."
The proportion of those having sex did decline somewhat with age. By ages 75 to 85, it was down to 39 percent of men and 17 percent of women.
Among those who remained sexually active, frequency also fell somewhat with age. But even among the oldest age group, 54 percent of those who were sexually active reported having sex at least two to three times per month and 23 percent reported having sex once a week or more.
"This just shows that the light doesn't go out. The flame doesn't go out," said Todd P. Semla, president of the American Geriatrics Society.
The most common sexual activity was vaginal intercourse. But the survey found a significant proportion reported engaging in oral sex, both giving and receiving, as well as masturbation.
Mirroring their younger counterparts, elderly men reported more sexual activity than women, but researchers said that was largely because women live longer than men, giving the surviving men more opportunities to have sex than women.
"This doesn't necessarily mean that women aren't necessarily interested in intimacy and sexuality," Lindau said. "A substantial number of women say the reason they are not having sex is they don't have a partner."
Among those who remained sexually active, nearly half reported at least one sexual problem. Forty-three percent of women reported a lack of sexual desire, 39 percent of women reported vaginal dryness, and 37 percent of men reported problems achieving an erection.
Given the availability of new medical treatments such as Viagra, those findings indicate that the elderly would benefit from more frank and open discussions about sex with their doctors.
"This should increase awareness among physicians to pay more attention to this," said John E. Morley, director of geriatrics at St. Louis University. "This is extraordinarily important, and we need to pay more attention to it."
Chemical in Bananas Identified as Potent Inhibitor of HIV Infection
5:04am EDT
100315091303
This is a 3-D structure of BanLec, a chemical isolated from bananas identified as a potent new inhibitor of HIV infection. (Credit: University of Michigan Medical School)
ScienceDaily (Mar. 16, 2010) — A potent new inhibitor of HIV, derived from bananas, may open the door to new treatments to prevent sexual transmission of HIV, according to a newly published University of Michigan Medical School study.
Scientists have an emerging interest in lectins, naturally occurring chemicals in plants, because of their ability to halt the chain of reaction that leads to a variety of infections. In laboratory tests, BanLec, the lectin found in bananas, was as potent as two current anti-HIV drugs. Based on the findings published March 19 in the
Journal of Biological Chemistry, BanLec may become a less expensive new component of applied vaginal microbicides, researchers say.
New ways of stopping the spread of the HIV are vitally needed. The rate of new infections of HIV is outpacing the rate of new individuals getting anti-retroviral drugs by 2.5 to1, and at present it appears an effective vaccine is years away.
"HIV is still rampant in the U.S. and the explosion in poorer countries continues to be a bad problem because of tremendous human suffering and the cost of treating it," says study senior author David Marvovitz, M.D., professor of internal medicine at the U-M Medical School.
Although condom use is quite effective, condoms are most successful in preventing infection if used consistently and correctly, which is often not the case. "That's particularly true in developing countries where women have little control over sexual encounters so development of a long-lasting, self-applied microbicide is very attractive," Markovitz says. Some of the most promising compounds for inhibiting vaginal and rectal HIV transmission are agents that block HIV prior to integration into its target cell.
The new research describes the complex actions of lectins and their ability to outsmart HIV. Lectins are sugar-binding proteins. They can identify foreign invaders, like a virus, and attach themselves to the pathogen.
The U-M team discovered BanLec, the lectin in bananas, can inhibit HIV infection by binding to the sugar-rich HIV-1 envelope protein, gp120, and blocking its entry to the body. Co-authors Erwin J. Goldstein, Ph.D., professor emeritus of biological chemistry at U-M and Harry C. Winter, Ph.D., research assistant professor in biological chemistry at U-M, developed the biopurification method to isolate BanLec from bananas. Following their work, the U-M team discovered BanLec is an effective anti-HIV lectin and is similar in potency to T-20 and maraviroc, two anti-HIV drugs currently in clinical use. Yet therapies using BanLec could be cheaper to create than current anti-retroviral medications which use synthetically produced components, plus BanLec may provide a wider range of protection, researchers say.
"The problem with some HIV drugs is that the virus can mutate and become resistant, but that's much harder to do in the presence of lectins," says lead author Michael D. Swanson, a doctoral student in the graduate program in immunology at the University of Michigan Medical School. "Lectins can bind to the sugars found on different spots of the HIV-1 envelope, and presumably it will take multiple mutations for the virus to get around them," he says. Swanson is developing a process to molecularly alter BanLec to enhance its potential clinical utility. Clinical use is considered years away but researchers believe it could be used alone or with other anti-HIV drugs as a vaginal microbicide that prevents HIV infection. Authors say even modest success could save millions of lives. Other investigators have estimated that 20 percent coverage with a microbicide that is only 60 percent effective against HIV may prevent up to 2.5 million HIV infections in three years.
Swanson et al. A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication. Journal of Biological Chemistry, 2010; 285 (12): 8646 DOI: 10.1074/jbc.M109.034926
Why Do Sexually Experienced Girls Resume Sexual Activity After Abstinence?
ScienceDaily (Mar. 15, 2010) — An Indiana University School of Medicine study provides a better understanding of why sexually experienced girls resume sexual activity after periods of abstinence, information key to dealing with sexually transmitted diseases (STDs) and pregnancy in high school girls and beyond.

While there has been a significant amount of research on teenagers' initial sexual experiences, the IU study is among the first to examine changes over time in decision-making about sexual abstinence among sexually active teenage girls. This information may help tailor effective counseling to prevent adolescent pregnancy and STDs.
The new findings are reported in the March 2010 issue of
Perspectives on Sexual and Reproductive Health.
Characteristics associated with the risk of a teen girl having sex after a period of abstinence differed according to how long she had been abstinent. In the short term, a young woman was more likely to have sex when her relationship with her partner was good, when the girl felt good and when she was interested in having sex. Long term, sexual interest and relationship quality were the two most important predictors of resumption of sex after a period of abstinence.
"Sexuality is an important developmental task for teens. They need to go from childhood to sexually mature adulthood while remaining sexually disease free and without getting pregnant. We conducted this study to better understand the factors that influenced teenage girls who became sexually active again after a period of abstinence. With this new understanding we can better help young women remain healthy and avoid unwanted pregnancy," said study first author Mary A. Ott, M.D., assistant professor of pediatrics at the Indiana University School of Medicine.
Diagnosis of a STD was associated with a reduced risk of subsequent sex for a short time. However having an STD increased risk for sexual activity in the intermediate time period and was unrelated to the decision to have sex in the long run. The study authors hypothesize that the switch may reflect either relationship turmoil after diagnosis of an STD, followed by "make up" sex, or may reflect adherence to Center for Disease Control and Prevention recommendations for a period of abstinence following STD treatment, followed by resumption of previous sexual activity.
"Either way, the findings suggest that counseling only about abstinence after a sexually transmitted infection is insufficient. Clinicians should anticipate resumption of sexual behavior and tailor counseling appropriately," said Dr. Ott.
The researchers also found that, in the short term, girls who characterized themselves as irritable, angry or unhappy were unlikely to return to sexual activity after a period of abstinence. That finding contradicts anecdotal information that depressed individuals are likely to engage in sexual activity.
The researchers evaluated 354 sexually active urban teen girls for up to four and a half years between 1999 and 2006. Study participants were 14 to 17 years old and not pregnant when they enrolled. Sexual experience was not an inclusion criterion, but 81 percent of participants were sexually experienced at enrollment; most of the others had their first sexual experience during the study period.
Participants reported a total of 9,236 abstinence periods, which averaged 31 days.
"Having data from the same group of young women over such a long period of time, as they go through periods of having sex and times when they are not having sex and as they change partners, enables us to understand a complex process of motivation in a way that previous studies have not. What we have established in this study are the major factors associated with the decision to resume sex," said study senior author J. Dennis Fortenberry, M.D., professor of pediatrics.
In addition to Dr. Ott and Dr. Fortenberry, co-authors of "Characteristics Associated with Sex After Periods of Abstinence Among Sexually Experienced Young Women" are Susan Ofner, M.S.; Wanzhu Tu, Ph.D., associate professor of medicine; and Barry P. Katz, Ph.D., professor of medicine. Dr. Tu is a Regenstrief Institute investigator. Dr. Katz is a Regenstrief affiliated scientist.
The study was funded by the National Institutes of Health.

More Women Having Wilder Sex, Watching Porn
Thursday, February 18, 2010
By Lyla Katz

LONDON — A new survey reveals more women are having wilder sex and watching porn.
The survey, done by the English Netmums website, found three-quarters of women having less sex because of longer work hours, but when they do have sex, they’re much more adventurous when compared to last year’s survey,
TheSun.co.uk reported.
The study shows 76 percent of women use porn, that’s a 10 percent rise from last year’s survey of women who admitted watching porn with their partners.
The most popular format is online porn, which is watched by 61 percent of couples.
Just one couple in 20 looks at magazines, while 18 percent watch porn DVD’s.
The survey of 4,200 women also revealed four in five women like to dress up and indulge in role play.
A French maid uniform is used by 42 percent of women, followed by nurses uniform, while 16 percent of couples like the policewoman uniform.
More than half of the women said they use sex toys in the bedroom to add excitement.
"Our survey shows they are taking control in the bedroom," Netmums founder Siobhan Freegard said. "They know what to do to get their sex lives back on track and are not afraid to experiment and introduce new methods to spice things up."
"During this age of multi-tasking, when we all wish there were 25 hours in a day, at least women are going after quality sex when they are having it," Katy Zvolerin, Adam & Eve's public relations director told XBIZ. "That women are willing to experiment more and become more adventurous says a lot. We are finding that themed lingerie, costumes and toys are much more popular than in years past, and a great way to add fun in the bedroom."
Last year’s survey showed more than half weren’t happy with their sex life, but this year more than 60 percent claimed to enjoy a fulfilling sex life.

http://www.sciencedaily.com/releases/2010/02/100204144815.htm
 


First Discovery of the Female Sex Hormone Progesterone in a Plant
Leaves of the walnut tree contain progesterone, the female sex hormone, discovered for the first time in a plant. (Credit: iStockphoto)
ScienceDaily (Feb. 7, 2010) — In a finding that overturns conventional wisdom, scientists are reporting the first discovery of the female sex hormone progesterone in a plant. Until now, scientists thought that only animals could make progesterone. A steroid hormone secreted by the ovaries, progesterone prepares the uterus for pregnancy and maintains pregnancy. A synthetic version, progestin, is used in birth control pills and other medications.The discovery is reported in the American Chemical Society's Journal of Natural Products.
"The significance of the unequivocal identification of progesterone cannot be overstated," the article by Guido F. Pauli and colleagues, states. "While the biological role of progesterone has been extensively studied in mammals, the reason for its presence in plants is less apparent." They speculate that the hormone, like other steroid hormones, might be an ancient bioregulator that evolved billions of years ago, before the appearance of modern plants and animals. The new discovery may change scientific understanding of the evolution and function of progesterone in living things. Scientists previously identified progesterone-like substances in plants and speculated that the hormone itself could exist in plants. But researchers had not found the actual hormone in plants until now. Pauli and colleagues used two powerful laboratory techniques, nuclear magnetic resonance and mass spectroscopy, to detect progesterone in leaves of the Common Walnut, or English Walnut, tree. They also identified five new progesterone-related steroids in a plant belonging to the buttercup family.
100204144815
Genital Herpes Virus Reactivates Widely Throughout Genital Tract
ScienceDaily (Jan. 30, 2010) — Genital herpes caused by a reactivation of herpes simplex virus type 2 (HSV-2) is generally treated as a lesion in one specific area of the genital region. A new study, however, finds that the virus can frequently reactivate throughout the genital tract, an important new concept that could help guide both HSV-2 treatment and prevention. Now available online, the study appears in the Feb. 15 issue of The Journal of Infectious Diseases.
In the study, Christine Johnston, MD, MPH, and colleagues at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle collected daily samples during a 30-day period from seven separate genital sites in four women infected with HSV-2. HSV-2 was detected from more than one anatomic site on 56 percent of days when there was viral shedding -- and on genital surfaces on both sides of the participants' bodies on most days when virus was detected at more than one site.
Using a detailed sampling method and a sensitive assay, the authors showed that both symptomatic and asymptomatic HSV-2 reactivations often occurred at widely spaced regions throughout the genital tract. These reactivations were often on both sides of the body, even though clinical lesions typically emanate from one anatomic spot. The study's findings illustrate an important new concept in HSV-2 pathogenesis, the authors wrote, and may help in developing comprehensive treatment that both suppresses and limits the transmission of HSV-2 infection.
The authors also noted limitations of their study, including a small sample size and the unique features of the study's subjects. For example, all participants had a history of symptomatic genital herpes, and three of the four had acquired HSV-2 infection within the past year, increasing the chances of high viral reactivation and lesion rates. Additionally, although there were a high proportion of days with lesions during the study period, two of the participants who had recently acquired genital herpes contributed the majority of lesion days.
In an accompanying editorial, Edward W. Hook III, MD, of the University of Alabama at Birmingham, called the study's findings "of great potential importance, as they further challenge widely held beliefs regarding genital herpes and, by extension, its management." Many clinicians treat patients with newly diagnosed herpes episodically, managing the signs and symptoms of periodic symptomatic recurrences, Dr. Hook wrote. "From a personal and public health perspective, the biology of the infection suggests that a national campaign for serological testing of those at risk would provide the foundation for more effective efforts to control HSV transmission to others, and that for most sexually active persons with HSV-2 whose sex partners are not known to also be infected, suppressive therapy should be the preferred approach."
Adapted from materials provided by Infectious Diseases Society of America.

TV Drama Can Be More Persuasive Than News Program, Study Finds
ScienceDaily (Feb. 11, 2010) — A fictional television drama may be more effective in persuading young women to use birth control than a news-format program on the same issue, according to a new study.
Researchers found that college-age women who viewed a televised drama about a teen pregnancy felt more vulnerable two weeks after watching the show, and this led to more support for using birth control.
However, those who watched a news program detailing the difficulties caused by teen pregnancies were unmoved, and had no change in their intentions to use birth control.
The results show the power that narratives like TV shows can have in influencing people, said Emily Moyer-Gusé, co-author of the study and assistant professor of communication at Ohio State University.
"A message that is hidden inside of a story may overcome some of the resistance people have to being told how to behave," Moyer-Gusé said.
"The impact that dramatized stories have on people's beliefs and intentions depends a lot on the individual viewers, and not just the message -- but our results suggest the effect can be there."
Moyer-Gusé conducted the study with Robin Nabi of the University of California, Santa Barbara. Their research appears in the current issue of the journal
Human Communication Research.
The study involved 353 undergraduate students between the ages of 18 and 25. All of them watched one of two programs that focused on the difficulties associated with unplanned teen pregnancies.
Half of the participants watched a program developed by the National Campaign to Prevent Teen Pregnancy to be broadcast on Channel One -- a news program that airs in many U.S. high schools. This program used a news format, and profiled male and female teen parents. The overall message was that teen pregnancy makes life as a young adult more difficult.
The remaining participants watched an episode of the U.S. teen drama,
The OC. In this episode, high-school students Ryan and Theresa faced the difficult consequences of an unintended pregnancy.
The programs were pre-tested with other students, who agreed that they both had the same main message concerning the difficulties of teen pregnancy.
Before watching the programs, participants completed questionnaires concerning how often they used some form of birth control if they were sexually active, and their intentions to use birth control over the next year.
Immediately after viewing the programs, participants filled out questionnaires concerning how much they were emotionally involved in the program, how much they identified with the characters, and other issues concerning their response to the programs they viewed.
Two weeks later, they were contacted again and asked about their intentions to use birth control.
The researchers found that male and females had different responses to the programs.
Watching the news-format program had no effect on men's safe-sex intentions two weeks later.
But two weeks after watching
The OC, men said they were actually less likely to follow birth control practices than they did before they viewed the program. That was probably because men reported they didn't like the program as much as women did, and didn't identify with the characters, Moyer-Gusé said.
Women had a different reaction to the programs. The news-format program had no effect on their intentions to use birth control. But those who watched
The OC episode were more likely to report in two weeks that they planned on taking steps to prevent pregnancy.
The findings revealed some of the underlying mechanisms that made the TV drama persuasive to many women viewers.
Findings showed that viewers who said they identified with the two main characters in
The OC episode also felt, when contacted two weeks later, that they were more vulnerable to an unplanned pregnancy. That, in turn, led to greater intentions to use birth control.
"Many of the women participants were able to put themselves in the place of the characters and sense they could end up in a similar situation if they weren't careful," Moyer-Gusé said.
Feeling vulnerable was the key to accepting birth control practices for the women in the study.
"One of the reasons why some people avoid safer sex behaviors is because they feel invulnerable -- they have this optimistic bias that nothing bad will ever happen to them," she said.
"But if you vicariously experience a bad result happening to you by watching a narrative program, that may change behavior in a way that is difficult to achieve through a direct message."
Participants, particularly women, were more likely to be persuaded to use birth control if they felt the program they watched didn't have an overt safe-sex message.
Most people didn't think
The OC episode was preaching the use of birth control, but those who did were much less likely to increase their intentions to use birth control, the findings showed.
In addition, those who reported that they reacted to the characters in
The OC as if they were friends were also less likely to see an overt message in the show, and were more likely to accept birth control practices.
Moyer-Gusé emphasized that the results don't mean that men aren't persuaded by narratives such as TV dramas.
"The show we chose happened to connect less with the men. But if we picked another topic or another show, I believe a narrative program could also be persuasive to male viewers."
While these results suggest persuasive messages might be better received by people if they are wrapped up in a story, Moyer-Gusé cautions that it isn't always that simple. As the different reactions of men and women
in this study showed, a lot depends on the individual viewers and not just the message.
"The problem with using stories to persuade people is that people can interpret them in different ways. You don't always get the results you expect," she said.


 http://www.sciencedaily.com/releases/2010/02/
 100209144153.htm
Science News
Web address:
Science Daily (July 15, 2009) — Condom use is associated with a reduced risk of contracting herpes simplex virus 2, according to a report based on pooled analysis of data from previous studies.
Herpes simplex virus 2 (HSV-2) typically causes genital herpes, a chronic, life-long, viral infection. Although studies indicate that consistent condom use reduces the spread of HIV and other sexually transmitted diseases such as chlamydia and gonorrhea, the effectiveness of preventing the transmission of HSV-2 through condom use is less certain, according to background information in the article.
Emily T. Martin, M.P.H., Ph.D., of Children's Hospital Research Institute and the University of Washington, Seattle, and colleagues analyzed data from six HSV-2 studies to assess the effectiveness of condom use in preventing the virus. The studies included three candidate HSV-2 vaccine studies, an HSV-2 drug study, an observational sexually transmitted infection (STI) incidence study and a behavioral STI intervention study. These yielded results from 5,384 HSV-2-negative individuals (average age 29) at baseline for a combined total of 2,040,894 follow-up days.
More than 66 percent of those who took part in the six studies were male, 60.4 percent were white, 94.1 percent were heterosexual and most reported no prior STIs.
A total of 415 of the individuals acquired HSV-2 during follow-up. "Consistent condom users [used 100 percent of the time] had a 30 percent lower risk of HSV-2 acquisition compared with those who never used condoms," the authors write. "Risk of HSV-2 acquisition decreased by 7 percent for every additional 25 percent of the time that condoms were used during anal or vaginal sex." The risk of acquiring the virus increased significantly with increasing frequency of unprotected sex acts. There were no significant differences found in condom effectiveness between men and women.
"Based on findings of this large analysis using all available prospective data, condom use should continue to be recommended to both men and women for reducing the risk of HSV-2 acquisition," the authors conclude. "Although the magnitude of the protective effect was not as large as has been observed with other STIs, a 30 percent reduction in HSV-2 incidence can have a substantial benefit for individuals as well as a public health impact at the population level."
Funding for this project was provided by grants from the National Institutes of Health, National Institute of Allergy and Infectious Diseases. 

Journal reference:
  • Emily T. Martin, MPH; Elizabeth Krantz, MS; Sami L. Gottlieb, MD, MSPH; Amalia S. Magaret, PhD; Andria Langenberg, MD; Lawrence Stanberry, MD, PhD; Mary Kamb, MD, MPH; Anna Wald, MD, MPH. A Pooled Analysis of the Effect of Condoms in Preventing HSV-2 Acquisition. Arch Intern Med, 2009;169(13):1233-1240 [link]
Adapted from materials provided by JAMA and Archives Journals.

Revision to the bible of psychiatry, DSM, could introduce new mental disorders
By Rob Stein Washington Post Staff Writer Wednesday, February 10, 2010; A01
Children who throw too many tantrums could be diagnosed with "temper dysregulation with dysphoria." Teenagers who are particularly eccentric might be candidates for treatment for "psychosis risk syndrome." Men who are just way too interested in sex face being labeled as suffering from "hypersexual disorder."
These are among dozens of proposals being unveiled Wednesday by the
American Psychiatric Association in the first complete revision since 1994 of the Diagnostic and Statistical Manual of Mental Disorders, or "DSM" -- the massive tome that has served as the bible for modern psychiatry for more than half a century.
The product of more than a decade of work by hundreds of experts, the proposed revisions are designed to bring the best scientific evidence to bear on psychiatric diagnoses and could have far-reaching implications, including determining who gets diagnosed as mentally ill, who should get powerful psychotropic drugs, and whether and how much insurance companies will pay for care.
"It not only determines how mental disorders are diagnosed, it can impact how people see themselves and how we see each other," said Alan Schatzberg, the association's president. "It influences how research is conducted as well as what is researched. . . . It affects legal matters, industry and government programs."
The proposals will be debated in an intense process over the next two years, with potentially billions of dollars at stake for pharmaceutical companies, insurance companies, government health plans, doctors, researchers and patient advocacy groups.
But perhaps more important, the outcome will help shape which emotions, behaviors, thoughts and personality traits society considers part of the natural spectrum of the human persona and which are considered pathological, requiring treatment and possibly even criminal punishment.
Even before being made public, the proposed changes have been the subject of sometimes bitter debate over whether the process was based on solid scientific evidence and was adequately shielded from influence by the pharmaceutical industry, and whether some critics were driven by financial interests in maintaining the old diagnostic criteria.
Supporters argue that the revisions would make diagnoses more accurate, creating more useful and precise definitions and sometimes reducing the number of psychiatric labels. For example, "autistic disorder" and "Asperger's disorder" would be replaced with a new, single category called "autism spectrum disorders." Critics, however, fear the new diagnoses could unnecessarily stigmatize many people and lead to the unnecessary use of psychiatric medications that can sometimes produce serious side effects.
"By massively pathologizing people under these categories, you tend to put them on an automatic path to medication, even if they are experiencing normal distress," said Jerome C. Wakefield, a professor of social work and psychiatry at New York University.
After being posted on the Internet, which of the proposed changes become final will be determined by a public comment period that will last until April 20, studies to validate some of the changes, further review, and votes by the association's Board of Trustees and Assembly. A final version is expected to be released by May 2013.
"We're mindful of the concern that we don't want to overdiagnose," Schatzberg told reporters during a telephone briefing Tuesday. "We want to, in fact, get an accurate assessment of what the degree of psychopathology might be in the culture."
Among the concerns are proposals to create "risk syndromes" in the hopes that early diagnosis and treatment will stave off the full-blown conditions. For example, the proposals would create a "psychosis risk syndrome" for people who have mild symptoms found in psychotic disorders, such as "excessive suspicion, delusions and disorganized speech or behavior."
"There will be adolescents who are a little odd and have funny ideas, and this will label them as pre-psychotic," said Robert Spitzer, a professor of psychiatry at Columbia University, who has been one of the most vocal critics of the DSM revision process.
Similarly, a proposal to create a new condition for people at risk for dementia could cause unnecessary anxiety, treatment and other harms, critics said.
"These people will never get long-term-care insurance if they have that on their chart," said Michael B. First, a professor of psychiatry at Columbia University.
William Carpenter of the University of Maryland, who chaired the working group that made the risk syndrome recommendation, acknowledged those concerns but said that experts decided that the potential benefits of early intervention warranted the move.
Others expressed concern about the proposals to create new conditions such as "temper dysregulation with dysphoria," or TDD. Supporters say it is intended to counter a huge increase in the number children being treated for bipolar disorder by creating a more specific diagnosis, though critics argued that it would only compound the problem of overtreatment.
"They are close to treating the children like guinea pigs. I think that's appalling and outrageous," said
Christopher Lane, author of "Shyness: How Normal Behavior Became a Sickness." "The APA should be moving to prevent such controversial practices, not encouraging them, as it is doing here."
In addition to classifying the symptoms of grief that many people experience after the death of a loved one as "depression," the proposals include adding "binge eating" and "gambling addiction" as bona fide psychiatric conditions; they also raise the possibility of making "Internet addiction" a future diagnosis. Some critics questioned the proposal to create a "hypersexual disorder."
"How many people with just healthy sex drives will be given that label?" First said.